Table 5.
Case # | Size (cm) | High-Grade Nuclei | Mitoses/50 HPFs | Necrosis | LVI | # of Atypical Features | Status at Last Follow-Up |
---|---|---|---|---|---|---|---|
1 | 6.5 | − | 8 | + | − | 3 | DOD |
2 | 3 | − | 2 | − | − | 1 | NED |
3 | 17 | + | 62 | + | + | 5 | AWD |
4 | 5 | − | 0 | − | − | 1 | NED (3 recurrences) |
5 | 0.2 | − | N/A | − | − | 0 | NED |
6 | 10 | + | 124 | + | − | 4 | DOD |
7 | 1.2 | − | N/A | − | − | 0 | DOC |
8 | 14 | + | 2 | + | − | 4 | DOD |
9 | 9 | + | 3 | + | − | 4 | AWD |
10 | 13.2 | + | 55 | + | + | 5 | DOD |
11 | 6 | + | 13 | + | − | 4 | AWD |
12 | 10.5 | + | 70 | − | − | 3 | DOD |
13 | 8 | + | 18 | + | + | 5 | AWD |
14 | N/A | − | 3 | − | − | 1 | NED |
15 | 6 | − | 0 | − | − | 1 | NED |
16 | 3.5 | − | 1 | − | − | 0 | NED |
18 | 2.5 | − | 4 | − | − | 1 | NED |
19 | 1.4 | − | 0 | − | − | 0 | NED |
20 | 0.4 | − | 0 | − | − | 0 | NED |
21 | 1 | − | 0 | − | − | 0 | NED |
22 | N/A | − | 0 | − | − | 0 | NED |
23 | 8 | − | 1 | − | − | 1 | NED |
24 | 7 | − | 9 | − | − | 2 | NED |
25 | 4 | − | 1 | − | − | 0 | NED |
26 | 3.8 | − | 0 | − | − | 0 | NED |
28 | 1 | − | 0 | − | − | 0 | NED |
29 | 4.5 | − | 13 | − | − | 1 | NED |
30 | 1.1 | − | 13 | − | − | 1 | NED |
31 | 4 | + | 133 | + | − | 3 | DOD |
32 | 3 | − | 2 | − | − | 1 | NED |
HPF=high-power fields; LVI=lymphovascular invasion; DOD=dead of disease; NED=no evidence of disease; DOC=dead of other causes; AWD=alive with disease; N/A=not available